Apollo Hospitals Enterprise Ltd
₹7542.50
(0.05%)
Sat, 14 Feb 2026, 06:26 pm
Apollo Hospitals Enterprise EV/EBITDA Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 47.85 | 26.97 | 37.44 | 24.61 | 32.88 | 32.79 | 39.19 | 38.10 | 40.22 | 55.89 | 77.95 | 73.47 | 125.91 | 71.98 | 34.81 | 270.20 | 61.52 | 75.65 | 101.64 | 65.85 |
| Price to book ratio | 4.15 | 3.40 | 2.29 | 1.67 | 2.74 | 3.10 | 3.43 | 4.22 | 4.28 | 5.99 | 5.53 | 4.90 | 4.55 | 5.10 | 4.74 | 9.07 | 11.55 | 10 | 13.17 | 11.59 |
| Price to sales ratio | 3.27 | 2.71 | 2.38 | 1.56 | 2.23 | 2.32 | 2.74 | 3.08 | 2.91 | 3.70 | 3 | 2.24 | 1.79 | 1.77 | 1.41 | 3.85 | 4.43 | 3.73 | 4.79 | 4.37 |
| Price to cash flow ratio | 27.11 | 25.62 | 43.26 | 32.64 | 27.66 | 31.57 | 26.50 | 31.53 | 48.49 | 52.24 | 42.08 | 53.92 | 61.58 | 30.44 | 21.29 | 49.10 | 43.97 | 52.75 | 55.13 | 49.37 |
| Enterprise value | 27.62B | 28.93B | 33.27B | 31.28B | 51.49B | 68.37B | 90.85B | 121.29B | 136.76B | 205.39B | 208.77B | 188.54B | 178.68B | 203.79B | 210.4B | 432.76B | 678.59B | 655.61B | 954.3B | 1010B |
| Enterprise value to EBITDA ratio | 22.65 | 18.83 | 18.07 | 15.16 | 16.92 | 16.14 | 17.58 | 19.81 | 20.24 | 27.81 | 29.68 | 25.38 | 22.06 | 18.86 | 13.14 | 37.15 | 30.75 | 31.53 | 39.59 | 32.94 |
| Debt to equity ratio | 0.46 | 0.47 | 0.41 | 0.45 | 0.55 | 0.50 | 0.33 | 0.44 | 0.45 | 0.63 | 0.85 | 0.94 | 1.05 | 1.10 | 1.68 | 0.90 | 0.72 | 0.70 | 0.77 | 0.96 |
| Return on equity % | 9.92 | 13.90 | 7.52 | 7.41 | 8.81 | 10.36 | 9.96 | 11.59 | 11.07 | 11.06 | 7.27 | 6.65 | 3.58 | 7.17 | 13.63 | 3.79 | 20.65 | 13.86 | 13.68 | 19.09 |
Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio
The Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Apollo Hospitals Enterprise Ltd's valuation, profitability, and overall financial performance. Tracking the Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Apollo Hospitals Enterprise Ltd (NSE: APOLLOHOSP, BSE: 508869) is currently trading at ₹7542.50, with a market capitalization of ₹1083.88B. As a leading company in the Health services sector and Hospital/Nursing management industry, monitoring the Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio Current Value
The current Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio stands at 32.94.
The Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 32.94
- 2023: 39.59
- 2022: 31.53
- 2021: 30.75
- 2020: 37.15
The decline in Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Apollo Hospitals Enterprise Ltd.
Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Apollo Hospitals Enterprise Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800